Blood test could outsmart scans in predicting childhood cancer relapse

NCT ID NCT07356882

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a simple blood test can better predict which children with Hodgkin lymphoma are at high risk of their cancer returning. Researchers will test blood samples from 400 children and young adults under 25 to look for tiny pieces of tumor DNA. The goal is to see if this 'liquid biopsy' can improve on current scan-based methods to help doctors personalize treatment intensity earlier.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLASSICAL HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Pediatric Hematology and Oncology Department
RECRUITING

Paris, 75012, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CLASSICAL HODGKIN LYMPHOMA